Oct 20
How COVID-19 reshaped the future of social security
A new study found that excess deaths from COVID-19 reduced future Social Security obligations by $205 billion. However, these fiscal "savings" highlight the profound human cost of the pandemic and do little to ease the overall strain on government finances or Social Security’s long-term solvency.
Oct 13
How tax regulation, transparency are reshaping cryptocurrency
As cryptocurrency use has skyrocketed, tax enforcement has struggled to keep up. A new study coauthored by Gies Business professor Tony Zhang finds that greater tax reporting transparency significantly boosts compliance, affects crypto prices, and offers key guidance for shaping future regulation.
Oct 09
Joseph Mahoney Wins 2025 Dan and Mary Lou Schendel Best Paper Prize
The Schendel Prize honors work that has had lasting influence on management teaching, research, and practice. Mahoney received the award for his paper “Modularity, Flexibility, and Knowledge Management in Product and Organization Design."
Oct 07
PODCAST: What's in a name? The secret to product survival in competitive industries
In this episode, we dive deep into the power of product names with Gies Professor Olga Khessina. Her research reveals that the name of a product could be the difference between success and failure.
Oct 06
Ren exploring how auditor-provided tax services impact auditor independence
Professor Bo Ren says his teaching will focus not just on the basics but also on the tools students need to succeed outside the classroom
Oct 02
The Pollution Shell Game
In an age where companies are eager to prove their environmental credibility, some are divesting "dirty assets" like plants that produce pollution. But what if that celebrated practice isn't actually addressing environmental harms? Where does industrial pollution go when companies divest?
Oct 01
Ocasio named SMS Fellow, completing elite trio at Gies Business
Gies College of Business professor William Ocasio has been named a Fellow of the Strategic Management Society (SMS), one of the field's highest honors.
Sep 25
Douglas Hannah joins Gies Business to study change in action
Gies Business is a fitting next step for a scholar like Hannah, whose research focuses on strategy and entrepreneurship: how people organize to have an impact.
Sep 24
PODCAST: Can clinical trial transparency stunt drug novelty?
In our latest episode, we're diving into the complexities of transparency in drug development and its surprising impact on innovation. Professor Hanu Tyagi explores the tension between openness and creativity in the pharmaceutical industry.